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I. Experimental Procedures 
a. General. 
Unless otherwise noted, all chemicals and reagents were obtained from suppliers Millipore Sigma and 
VWR and were used without further purification. NMR spectra were obtained using a Varian Innova 
300 MHz, Bruker Prodigy 400 MHz, or Varian Innova 500 MHz instrument, using DMSO-d6 as the 
solvent and are referenced to residual solvent signals. Data for 1H NMR are reported in the 
conventional form: chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, hept = heptet, m = multiplet, br = broad), coupling constant (Hz), and integration. Sonication 
was performed using a Qsonica Q500 sonicator. Chemical reactions were monitored using thin layer 
chromatography (Merck 60 silica gel plates) and a UV lamp for visualization, if possible.  
b. Chromatography. 
Reverse-phase high-performance liquid chromatography (HPLC) and liquid chromatography-mass 
spectroscopy (LC-MS) were carried out using Agilent 1200 series instruments and an Agilent XDB-
C8 column (4.6 x 150 mm, 5 µm) with water and acetonitrile as the mobile phase. Both water and 
acetonitrile contained 0.1% acetic acid. Semi-preparative HPLC was performed using an Agilent 
XDB-C18 column (9.4 x 250 mm, 5 µm) with water and acetonitrile containing 0.1% acetic acid. 
Analytical chiral HPLC was performed using a Daicel Chiralpak IC column (4.6 x 250 mm, 5 µm) 
with hexanes and isopropanol as the mobile phase. 
c. Cloning and site-saturation mutagenesis. 
Plasmid pET22b(+) (Novagen) was used as a cloning and expression vector for all variants described 
in this paper. Site-saturation mutagenesis was performed using modified QuikChange
TM
 mutagenesis 
protocol using 22-codon trick.
1
 The PCR products were further digested with DpnI, purified with 
New England Biolabs gel purification kit, and the gaps were repaired using Gibson Mix
TM
.
2
 Without 
further purification, 1 µL of the ligation mixture was used to transform 50 μL of electrocompetent E. 
coli strain BL21 E. cloni (Lucigen).  
d. Cloning for cytochrome c. 
The gene encoding Rhodothermus marinus cytochrome c (UNIPROT ID B3FQS5) was originally 
obtained as a single gBlock (IDT), codon-optimized for E. coli, and cloned using Gibson assembly 
into pET22b(+) between restriction sites NdeI and XhoI in frame with an N-terminal pelB leader 
sequence and a C-terminal His-tag. This plasmid was used as the basis of all Rma cytochrome c 
S３ 
variants described in this study. All plasmids and ligation mixtures containing the gene encoding a 
cytochrome c variant were co-transformed with the cytochrome c maturation plasmid pEC86
3
 
encoding the gene ccmABCDEFG for maturation into BL21 E. cloni (Lucigen). 
Cytochrome c site-saturation mutagenesis was performed using a further modified protocol with 
22-codon trick. Instead of one long-range PCR of the entire plasmid, two PCRs were performed, 
pairing the forward site-saturation primer mixture with a pET22b(+) internal reverse primer, and the 
reverse site-saturation primer mixture with a pET22b(-) internal forward primer. The two PCR 
products were purified together using New England Biolabs gel purification kit, and the gaps were 
repaired using Gibson Mix. The ligation mixture was then used directly for co-transformation with 
the pEC86 plasmid into BL21 E. cloni electrocompetent cells. 
e. Expression of P411BM3, globin, and cytochrome c variants.  
Escherichia coli BL21 E. cloni electrocompetent cells were transformed with pET22b(+) constructs 
encoding various P411BM3 and protoglobin variants. The cells were grown overnight in 6-mL Luria-
Bertani (LBamp) medium, supplemented with ampicillin, and 5 mL of this preculture were used to 
inoculate 45 mL of Hyperbroth (HBamp) medium. The expression culture was incubated at 37 °C and 
250 rpm for two hours. Then, the expression culture was cooled on ice for 20 minutes and was 
induced with 1 mM 5-aminolevulinic acid (ALA) and 0.5 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG), final concentrations. Cells were allowed to express at 22 °C and 130 rpm for 24 hours. Once 
expression was finished, the cultures were centrifuged (4,000 g, 5 minutes, and 4 °C) and the pellets 
were resuspended to an OD600 of 30 in M9-N minimal medium at pH 7.4. 
To express cytochrome c variants, E. coli BL21 E. cloni electrocompetent cells were transformed 
with pET22b(+) constructs encoding various cytochrome c variants, along with the pEC86 construct 
for cytochrome c maturation. The cells were grown overnight in 5 mL Luria-Bertani (LBamp+chl) 
medium, supplemented with ampicillin and chloramphenicol, and 0.5 mL of this preculture were used 
to inoculate 30 mL of Hyperbroth (HBamp+chl) medium. The expression culture was incubated at 37 °C 
and 250 rpm until an OD600 of 0.5 – 0.7 was reached. Then, the expression culture was cooled on ice 
for 25 minutes and was induced with 200 µM ALA and 20 µM IPTG, final concentrations. Cells were 
allowed to express at 22 °C and 250 rpm for 20 – 24 hours. Once expression was finished, the 
cultures were centrifuged (4,000 g, 5 minutes, 4 °C) and the pellets were resuspended to an OD600 of 
30 in M9-N minimal medium at pH 7.4. 
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f. Purification of cytochrome c variants. 
Harvested cells from 300 – 600 mL of expression cultures were resuspended in buffer containing 200 
mM potassium phosphate, 100 mM NaCl, and 20 mM imidazole (pH is adjusted to 7.5 at 25 °C). 
Cells were lysed by sonication (4 minutes, 1 seconds on, 1 seconds off, 40% intensity; Qsonica Q500 
sonicator). The sonication was repeated once more, and then the partially lysed cells were placed in a 
55 °C heat bath for 20 minutes and then moved to 75 °C heat bath for an additional 10 minutes. The 
cell debris was removed by two serial centrifugation steps (5,500 g, 20 minutes, 4 °C and then 30,000 
g, 30 minutes, 4 °C). The supernatant was filtered through a 0.2-µm cellulose acetate filter and 
purified using a 1-mL Ni-NTA column using AKTA purifier FPLC system by running a gradient 
from 20 mM to 500 mM imidazole over 10 column volumes. Pure fractions were determined using 
SDS-PAGE and were pooled and concentrated using a 3-kDA molecular weight cut-off centrifugal 
filter. The concentrated fractions were washed twice with 0.1 M phosphate buffer at pH 7.5 and were 
dialyzed overnight into 0.05 mM phosphate buffer at pH 7.5 using a 3-kDA molecular weight cut-off 
dialysis tubing. The dialyzed protein was frozen on dry ice and stored at -20 °C. 
g. Reaction setup and product characterization.  
In preparation for the reaction, a 250-mM glucose solution was prepared in M9-N medium (pH 7.4), 
filtered through a 0.2-µm cellulose acetate filter, and placed in the anaerobic chamber for at least a 
day. The cells were degassed by sparging with argon for 30 minutes at 4 °C. To 2-mL screw cap vials 
were added 20 µL of a stock solution containing 1,000 U/mL glucose oxidase and 14,000 U/mL 
catalase prepared in double-distilled water. Resuspended cells were added to the screw cap vials, and 
all vials containing cells or reagent were immediately transferred into an anaerobic chamber with 
oxygen concentration below 15 ppm. In the chamber, 40 µL of the glucose solution and the reagents 
(typically 200 mM-1 M stocks in DMSO) were added. The final reaction volume was 400 µL for all 
reactions on analytical scale. The reaction mixture was typically shaken at room temperature for 24 
hour at 600 rpm. After completion of the reaction, acetonitrile was added to quench the reaction and 
precipitate protein. The mixture was frozen for 4 hours at -20 °C and then defrosted at room 
temperature for an hour to encourage cell lysis. The defrosted mixture was transferred to a 1.7-mL 
microcentrifuge tube and was centrifuged at 14,000 g for 5 minutes. To determine the yield, 200 µL 
of the supernatant were transferred to an HPLC vial with insert and analyzed by reverse-phase HPLC-
MS. Protein concentration in the cell was determined by performing hemochrome assay on the cell 
lysate. Lysate was obtained by sonication (4 minutes, 1 seconds on, 1 seconds off, 40% intensity) 
followed by centrifugation (4,500 g, 10 minutes, 4 °C) to remove cell debris. 
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In order to determine the enantioselectivity, acetonitrile was removed from the remaining 
supernatant, and the solution was made more basic by adding 80 µL of 1 M NaOH (aq). For 
derivatization, 10 – 15 µL of 10% benzoyl chloride solution in acetonitrile were added, and the 
solution was allowed to shake at room temperature (25 °C) and 600 rpm for 4 hours. Derivatized 
product was extracted with ethyl acetate and analyzed by chiral normal-phase HPLC to determine the 
enantiomeric excess (ee). 
h. Reaction screening in 96-well plate format. 
After a single-site-saturation library was generated, 88 single colonies were randomly picked and 
cultured in 300 μL of LB medium with 0.1 mg/mL ampicillin (LBamp) in a sterilized 96-well culture 
plate. The plate contained four wells inoculated with parent single colonies, and four sterile wells. 
The cells in LB medium were cultured at 37°C, 230 rpm, and 80% relative humidity for 10-12 hours. 
A separate sterilized 96-well culture plate was filled with 1000 μL of Hyperbroth medium containing 
0.1 mg/mL ampicillin (HBamp) in each well. The new plate with HBamp was inoculated with the LB 
preculture (50 μL/well) and incubated at 37°C, 230 rpm, and 80% relative humidity for 3 hours. The 
plate was cooled on ice for 30 minutes, induced with 20 μM IPTG and 200 μM 5-aminolevulinic acid 
(final concentrations), and then expression was conducted at 22 °C and 230 rpm for 20 hours. The 
cells were pelleted (4,500 g, 5 minutes), an oxygen depletion system
4
 (20 μL/well of a stock solution 
containing 14,000 U/mL catalase from Corynebacterium glutamicum and 1,000 U/mL glucose 
oxidase from Aspergillus niger in M9-N medium) was added, and the mixture was gently 
resuspended. The 96-well plate was transferred to an anaerobic chamber, where argon-sparged 50 
mM D-glucose in 0.1 M potassium phosphate buffer (pH 8.0) was added (300 μL/well). The nitrene 
source (10 μL/well, 400 mM in DMSO) and the alkene (10 μL/well, 400 mM in DMSO) were 
subsequently added, and the plate was sealed with an aluminum foil and shaken at 600 rpm at room 
temperature for 20-24 hours. 
Once the plate was taken out of the anaerobic chamber and the seal was removed, acetonitrile 
(800 μL/well) and internal standard (10 μL/well of a 200mM DMSO stock) were added. The wells 
were mixed by pipetting and the plate was left to shake at 600 rpm at room temperature for an hour. 
The plate was then centrifuged (5,000 g, 5 minutes), and the supernatant (200 μL/well) was filtered 
through an AcroPrep 96-well filter plate (0.2 μm) into a shallow 96-well plate for reverse-phase 
HPLC-MS analysis. 
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i. Protein lysate preparation. 
Protein-containing lysate was prepared from pelleted and resuspended cells adjusted to a given OD600. 
Protein lysates for P450s were obtained by sonication (1 second on, 1 second off, 3 minutes with 30% 
- 40% amplitude, on wet ice) in the presence of BugBuster
TM
 reagent. The sonicated cell mixture was 
distributed into 2.0-mL Eppendorf tubes and then centrifuged (14,000 g, 10 minutes, 4 °C) to remove 
cell debris. The supernatant was immediately transferred to a different container, filtered through a 
0.45 μm cellulose filter, and used to determine protein concentration. Protein lysates for cytochrome c 
variants were obtained by freezing at -20 °C for 3 hours, then thawing and performing a heat 
treatment (55 °C, 25 minutes). The heat-treated mixture was centrifuged (5,000 g, 10 minutes, 4 °C) 
to remove cell debris. The supernatant was filtered through a 0.2 µm cellulose filter. 
j. Determining protein concentration. 
All hemoprotein concentrations were determined in triplicate using the hemochrome assay. A solution 
of 1 M NaOH (0.4 mL) was mixed with pyridine (1 mL) in a 1.7 mL-Eppendorf tube. The tube was 
centrifuged (14,000 g, 1 minutes) to separate the excess aqueous layer and give a pyridine-NaOH 
solution on top. Separately, a solution of sodium dithionite (10 mg/mL) was prepared in a potassium 
phosphate buffer (pH 8.0). To a cuvette containing 800 µL protein solution in potassium phosphate 
buffer (pH 8.0), 50 µL of dithionite solution and 150 µL pyridine-NaOH solution were added. The 
solution was mixed, the cuvette was sealed with Parafilm, and the UV-Vis spectrum of the reduced 
hemoprotein was recorded immediately. Hemoprotein concentrations were determined using ε550-535 = 
22.1 mM
-1
cm
-1
 for heme c.
5
 This value was also compared with an alternative method of hemochrome 
assay where potassium ferricyanide solution is used,
6
 and the agreement was within 3%. 
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II. Supplementary Figures and Tables 
Supplementary Table 1. Aminohydroxylation of 4-vinylanisole (3) with variants of cytochrome P450BM3. 
(a) 
 
Variant Mutations relative to the wild-type P450BM3 Yield [%] 
pET22b(+) vector N/A: not expressing any hemoprotein 0.9 
P450BM3 none 0.8 
P411BM3 C400S 4.1
(b)
 
P411BM3 T268A T268A, C400S 2.4 
P411BM3 F87A T268A 
(c)
 F87A, T268A, C400S 1.5 
P411BM3 F87V T268A F87V, T268A, C400S 1.2 
P411BM3 CIS T438S 
(“P”) 
V78A, F87V, P142S, T175I, A184V, S226R, H236Q, E252G, 
T268A, A290V, L353V, I366V, C400S, T438S, E442K 
1.9 
P411BM3 CIS T438S 
A268T 
V78A, F87V, P142S, T175I, A184V, S226R, H236Q, E252G, 
A290V, L353V, I366V, C400S, T438S, E442K 
1.7 
“P-I263F” (c) 
V78A, F87V, P142S, T175I, A184V, S226R, H236Q, E252G, I263F, 
T268A, A290V, L353V, I366V, C400S, T438S, E442K  
2.4 
“P-I263F” F263M P-I263F I263M 1.3 
“P-I263F” F263Y P-I263F I263Y 1.2 
“P-I263F” A328V P-I263F A328V 3.4(b) 
“P-I263F” V87A A328V P-I263F F87A A328V 1.4 
“A10” (d) P-I263F A328V, L437V 1.9 
“A10” C400H P-I263F A328V, C400H, L437V 1.2 
“A10” C400A P-I263F A328V, C400A, L437V 1.2 
“A10” C400 
V78A, F87V, P142S, T175I, A184V, S226R, H236Q, E252G, I263F, 
T268A, A290V, A328V, L353V, I366V, L437V, T438S, E442K 
1.0 
P-I263F V87A A328V 
A268G A82I (“A82I”) 
P-I263F A82I, F87A, T268G, A328V 1.1 
P-I263F V87A A328V P-I263F A82L, F87A, T268G, A328V 1.2 
S８ 
A268G A82L (“A82L”) 
"A82L" A78V F263L 
E267D 
P-I263F A78V, A82L, F87A, F263L, E267D, T268G, A328V 1.7 
“A82L” A78V F263L  P-I263F A78V, A82L, F87A, F263L, T268G, A328V 1.1 
P411BM3 H2-4-D4 
L75A, V78A, F87V, P142S, T175I, M177A, L181A, A184V, S226R, 
H236Q, E252G, T268A, A290V, L353V, I366V, C400S, L437A, 
E442K 
4.4
(b)
 
P411BM3 H2-A-10 
L75A, V78A, F87V, P142S, T175I, L181A, A184V, S226R, H236Q, 
E252G, T268A, A290V, L353V, I366V, C400S, E442K 
3.8
(b)
 
P411BM3 H2-5-F10 
L75A, V78A, F87V, P142S, T175I, A184V, S226R, H236Q, E252G, 
I263A, T268A, A290V, L353V, I366V, C400S, L437A, E442K 
1.5 
P411BM3 CIS I263W 
C400H 
V78A, F87V, P142S, T175I, A184V, S226R, H236Q, E252G, 
I263W, T268A, A290V, L353V, I366V, C400H, E442K  
1.1 
P411BM3 CIS L437F 
T438Q 
V78A, F87V, P142S, T175I, A184V, S226R, H236Q, E252G, 
T268A, A290V, L353V, I366V, C400S, L437F, T438Q, E442K 
1.4 
P411BM3 CIS L437F 
T438Q L75Y 
L75Y, V78A, F87V, P142S, T175I, A184V, S226R, H236Q, E252G, 
T268A, A290V, L353V, I366V, C400S, L437F, T438Q, E442K 
1.3 
P411BM3 CIS L437F 
T438Q L181V 
V78A, F87V, P142S, T175I, L181V, A184V, S226R, H236Q, 
E252G, T268A, A290V, L353V, I366V, C400S, L437F, T438Q, 
E442K 
1.5 
P411BM3 CIS L437F 
T438Q L75Y L181I 
L75Y, V78A, F87V, P142S, T175I, L181I, A184V, S226R, H236Q, 
E252G, T268A, A290V, L353V, I366V, C400S, L437F, T438Q, 
E442K 
1.3 
P411BM3 CIS I263G 
L437F 
V78A, F87V, P142S, T175I, A184V, S226R, H236Q, E252G, 
I263G, T268A, A290V, L353V, I366V, C400S, L437F, E442K 
1.4 
P411BM3 CIS I263G 
L437F V87L 
V78A, F87L, P142S, T175I, A184V, S226R, H236Q, E252G, I263G, 
T268A, A290V, L353V, I366V, C400S, L437F, E442K 
2.0 
P411BM3 CIS I263G 
L437F V87L L181R 
V78A, F87L, P142S, T175I, L181R, A184V, S226R, H236Q, 
E252G, I263G, T268A, A290V, L353V, I366V, C400S, L437F, 
E442K 
2.1 
P411BM3 CIS V87T 
T438C 
V78A, F87V, P142S, T175I, A184V, S226R, H236Q, E252G, 
T268A, A290V, L353V, I366V, C400S, T438C, E442K 
1.2 
P411BM3 CIS V87T 
I263G L437F T438C 
Q674STOP 
V78A, F87T, P142S, T175I, A184V, S226R, H236Q, E252G, I263G, 
T268A, A290V, L353V, I366V, C400S, L437F, T438C, E442K, 
Q674STOP 
1.6 
 
(a) Reactions were performed using whole cells at OD600 = 30 with 5 mM of each substrate; results are the 
average of duplicate reactions. N.D. = none detected. 
S９ 
(b) Enantiomeric excess was measured for P450BM3 variants that gave highest yields. The ee ranged from 0 to 
11%, with P411BM3 giving 11% ee. 
(c) Variants identified for regioselective intramolecular C-H amination.
7
 
(d) Variant identified for aziridination of styrenes.
8
 
 
Supplementary Table 2. Aminohydroxylation of 4-vinylanisole with hemin and various hemoproteins. 
(a) 
 
Catalyst Note Yield [%] 
Whole cells expressing pET22b(+) 
pEC86 vector 
pEC86 encodes ccmABCDEFG to aid the 
maturation of cytochrome c proteins 
0.8 
Hemin 
(b)
 Concentration: 10 µM 0.1 
Hemin + imidazole 
(b)
 10 µM hemin + 1 mM imidazole 0.08 
Hemin + bovine serum albumin 
(b)
 Concentration: 10 µM each 0.1 
Bovine serum albumin only Concentration: 10 μM N. D. 
Myoglobin From equine heart, concentration: 10 µM 2.2 
Rhodothermus marinus (Rma) 
cytochrome c 
 4.0 
(c)
 
Hydrogenobacter thermophilus 
cytochrome c 
 1.1 
Rhodopila globiformis cytochrome c  1.0 
Rma cytochrome c M100D  2.9 
Rma cytochrome c “TDE” (d) Mutations from the wildtype: V75T M100D M103E 3.8 
 
(a) Reactions were performed with 5 mM of each substrate; results are the average of triplicate reactions. N.D. = 
none detected. Whole cells resuspended in M9-N medium to OD600 = 30 were generally used, unless otherwise 
specified. 
S１０ 
(b) Hemin and other additives were dissolved in M9-N medium without any whole cells to specified final 
concentrations. Hemin was reduced using sodium dithionite solution (10 mg/mL) prior to reaction. 
(c) Enantiomeric excess was measured for the product of wild-type Rma cytochrome c reaction. It was determined 
to be 32 % ee. 
(d) Variant identified for carbene Si-H insertion.
9
 
 
Supplementary Table 3. Aminohydroxylation data presented in Figure 2A of the main text. 
 
Variant Mutations from the wild-type Rma cytochrome c TTN Yield [%] ee [%] 
Rma cytochrome c None 40 4.8 32 
“M100S” M100S 56 5.3 39 
“SG” M100S, M103G 74 7.2 60 
“SPG” M100S, T101P, M103G 86 7.3 51 
“VSPG” M99V, M100S, T101P, M103G 360 15.0 73 
VSPG T98L T98L, M99V, M100S, T101P, M103G 640 25.8 76 
VSPG M76Q T98L M76Q, T98L, M99V, M100S, T101P, M103G 1800 76.1 85 
“TQL” Y44T, M76Q, T98L, M99V, M100S, T101P, M103G 2500 90.4 90 
 
Reactions were performed using whole cells at OD600 = 30 with 10 mM of each substrate; results are the average 
of triplicate reactions. Site-saturation libraries were generated and tested in the 96-well expression and reaction 
format discussed in the general procedures. Beneficial mutations were identified, and the best variants were 
grown in 30 mL expression cultures and re-tested. The TTN and ee reported in this table are obtained with the 
cultures grown at 30-mL scale. 
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Supplementary Table 4. Summary of directed evolution for aminohydroxylation. 
Generation Parents Saturated sites Mutation identified 
1 Wildtype Rma cyt c M100X M100S, M100H 
2 M100S, M100H M103X M100S M103G (“SG”) 
3a “SG” V75X, L105X None 
3b “SG” T101X T101A, T101P 
4a “SG” T101A 
M99X T101P M99V (“VSPG”) 
4b “SG” T101P 
5 “VSPG” T98X T98L 
6 “VSPG” T98L M76X, Y44X M76Q 
7 “VSPG” M76Q T98L Y44X Y44T 
 
Reactions were performed in the 96-well expression and reaction format, with 10 mM of each screening 
substrates. Active site residues T98, M99, M100, T101, M103, and L105 are located in the loop distal to the heme 
cofactor of Rma cytochrome c. Active site residues V75 and M76 are located on the helix on the distal face of 
heme. Y44 is near the region where the active site is exposed to the aqueous environment. 
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Supplementary Table 5. Description of the substrate scope presented in Scheme 1 of the manuscript. 
Product OD600 Reactant concentration Temperature TTN Yield [%] ee [%] 
4 30 10 mM each RT 2500 90.4 90 
5 30 10 mM each RT 470 20.1 63 
6 60 10 mM each 7 °C 
(a)
 1900 96.5 80 
7 60 10 mM each RT 180 
(c)
 12.2 67 
8 30 10 mM each RT 1700 60.3 53 
9 30 
10 mM olefin substrate,  
25 mM nitrene precursor 1 
RT 1200 50.8 92 
10 30 
10 mM olefin substrate,  
20 mM nitrene precursor 1 
RT 190 
(c)
 8.5 88 
11 30 
10 mM olefin substrate,  
20 mM nitrene precursor 1 
RT 330 13 92 
12 30 
10 mM olefin substrate,  
20 mM nitrene precursor 1 
37 °C 150 
(c)
 7.3 82 
13 60 20 mM each 37 °C 80 
(c)
 8.6 80 
14 30 
10 mM olefin substrate,  
30 mM nitrene precursor 1 
20 °C  2400 77.2 85 
15 30 10 mM each RT 750 27.8 45 
16 30 10 mM each RT 2400 
(b)
 76.8 93 
(d)
 
 
Room temperature (RT) was typically 23 – 25 °C. Reactions performed at specified temperatures other than RT 
were shaken in a temperature-controlled shaker. Nitrene precursor 1 was used for all reactions. 
(a) Olefin reagents were light or temperature sensitive, and often generate white precipitate during room 
temperature reactions.  
(b) For this substrate, TTN was calculated as the concentration of all aminohydroxylation products over the 
concentration of protein. 
(c) Cells were allowed to express protein at 25 °C, yielding higher concentration of protein for a given OD600.  
(d) The product has diastereomeric ratio of 87:13 for (1R,2S)-(1S,2R)-15 and (1R,2R)-(1S,2S)-15, respectively. 
The ee refers to the major diastereomer only. 
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Supplementary Figure 1. Mechanistic hypothesis for styrenyl olefin hydroxylation. 
 
Two processes for olefin aminohydroxylation are possible, involving either a nitrene or nitrene radical 
intermediate. Nitrene transfer to styrene could give an aziridine, which can hydrolyze to the amino alcohol 
product. Alternatively, a nitrene radical intermediate may give rise to carbon-centered radical or a carbocation 
intermediate, which may either rearrange to the aziridine or proceed to the amino alcohol product without the 
intermediacy of an aziridine species. 
 
Supplementary Figure 2. Substrates showing low reactivity (<30 TTN) toward aminohydroxylation by the 
cytochrome c TQL variant. 
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III. Synthesis of Substrates and Product Standards. 
Most chemicals were purchased from commercial vendors and were used without further purification. All 
olefin substrates and product standards were purchased from commercial suppliers (Fisher Scientific, 
Enamine, Millipore Sigma, VWR, TCI America). Nitrene precursors were synthesized. All nitrene 
precursors are known compounds, and their spectral data are in agreement with reported values. 
a. Nitrene precursor 1 (O-pivaloylhydroxyamine triflic acid). 
Pivalic anhydride (18.3 mL, 90.1 mmol) was added to a solution of N-Boc hydroxylamine (10.0 g, 75.1 
mmol) in chloroform (200 mL). The reaction mixture was refluxed for 16 hours. The mixture was then 
quenched with saturated sodium bicarbonate solution and diluted with dichloromethane. The organic 
phase was washed three times with saturated sodium bicarbonate solution. The organic phase was then 
dried with magnesium sulfate, filtered, and evaporated under reduced pressure. The white solid obtained 
was dissolved in anhydrous diethylether (200 mL) and cooled on an ice water bath. Triflic acid (7.2 mL, 
81.2 mmol) was added dropwise. The reaction was then allowed to reach room temperature and was 
diluted with hexanes to precipitate the product. The product was obtained by filtration, and excess solvent 
was removed under reduced pressure. The product is a white solid (10.5 g, 52% over 2 steps). The NMR 
spectrum agreed with the spectrum previously reported.
10
 
1
H NMR (400 MHz, DMSO-d6): δ 1.20 (s, 9H). 
b. Nitrene precursor 17 (O-(tert-butoxycarbonyl)hydroxylamine). 
Hydroxylamine hydrochloride (1.94 g, 28 mmol) in 50 mL 50% (v/v) dioxane was adjusted to pH 10 with 
4 N sodium hydroxide, on ice water bath. Di-tert-butyl dicarbonate (15.7 g, 72 mmol) was added and the 
pH was maintained at 10 by additional adjusting with sodium hydroxide. After 30 minutes, the reaction 
was allowed to reach room temperature, and a small amount of distilled water was added to dissolve 
precipitate. After 90 minutes, 3 N hydrochloric acid was added to acidify the solution to pH 2, and the 
product was extracted three times with 50 mL chloroform. The chloroform solution was washed with 
brine, dried over magnesium sulfate, and evaporated under reduced pressure. Tert-butanol and excess 
solvent were further evaporated by freeze-pump-thaw under reduced pressure. The product was a clear 
liquid at room temperature (2.66 g, 20 mmol). The NMR spectrum agreed with the spectrum of 16 
reported.
11
 
1
H NMR (400 MHz, DMSO-d6): δ 1.48 (s, 9H). 
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c. Nitrene precursor 18 (O-pivaloylhydroxyamine trifluoroacetic acid). 
Pivalic anhydride (3.66 mL, 18.0 mmol) was added to a solution of N-Boc hydroxylamine (2.00 g, 15.0 
mmol) in chloroform (40 mL). The reaction mixture was refluxed for 16 hours. The mixture was then 
quenched with saturated sodium bicarbonate solution and diluted with dichloromethane. The organic 
phase was washed three times with saturated sodium bicarbonate solution. The organic phase was then 
dried with magnesium sulfate, filtered, and evaporated under reduced pressure. The white solid obtained 
was dissolved in anhydrous diethylether (40 mL). Trifluoroacetic acid (1.4 mL) was added dropwise at 0 
°C. The reaction was allowed to reach room temperature and was diluted with hexanes to precipitate the 
product. The reaction mixture was filtered to obtain the desired product as a white solid (1.40 g, 35%). 
The NMR spectrum agreed with the spectrum for nitrene precursor 1.  
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IV. Characterization of Products and HPLC Calibration Curves 
UV absorbance of the product standards was plotted as a function of the product concentration. Data were 
fitted with a linear trendline with zero intercept to show the linearity of UV absorption. Calibration curves 
with an internal standard were created for the determination of yield and TTN. The concentration of 
analytes was plotted as a function of the UV absorbance ratio of the analyte over an appropriate internal 
standard. Product standards analyzed based on absorbance at 254 nm or shorter wavelengths were 
calibrated with 1,3,5-trimethoxybenzene (1.25 mM, final concentration) as the internal standard. Product 
standards analyzed based on absorbance at 280 nm were calibrated with acetophenone (1.25 mM, final 
concentration) as the internal standard. The identity of the products was confirmed by HPLC-MS co-
injections of reaction mixtures with authentic product standards. 
The appropriate wavelength for each compound was determined based on their UV absorption 
maxima, retention time using the reverse-phase HPLC method, and the presence of cell impurities sharing 
the same retention time. Methods were adjusted so that none of the products elute at the same time with 
any of the cell impurities. For all analysis, water and acetonitrile containing 0.1% acetic acid were used as 
eluents. The method used 5 – 40% acetonitrile (0 – 3 minutes), 40 – 95% acetonitrile (3 – 4 minutes), 
95% acetonitrile (4 – 5 minutes), followed by one minute of postrun (5% acetonitrile). The flow rate was 
1.5 mL/minute, and the column was maintained at 37 °C for the entire method. 
Product Absorbance vs. concentration Calibration with internal standard 
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V. Derivatization of Amino Alcohol Products 
 
Commercially available product standards 4 – 16 were dissolved in DMSO to make 200 mM stock 
solutions. To derivatize the product standards, 4 - 20 µL of the 200 mM stock solution was added to 310 
µLof KPi (0.1 M, pH 8.0) containing 150 mM sodium chloride to mimic enzymatic reaction in whole 
cells. Saturated sodium bicarbonate solution (50 µL) and benzoyl chloride stock solution (10 µL, 10% v/v 
in acetonitrile) was added to the KPi solution. The mixture was allowed to shake at room temperature at 
750 rpm for at least 3 hours.  
The supernatant of centrifuged whole cell reaction mixtures quenched with acetonitrile was dried 
overnight in the fume hood prior to derivatization, to remove acetonitrile. Once the volume of the 
supernatant was roughly under 300 µL, saturated sodium bicarbonate solution (50 µL) and benzoyl 
chloride stock solution (10 µL, 10% v/v in acetonitrile) was added. Greater than 10-fold excess of 
benzoyl chloride was used for all derivatization. The mixture was vortexed and then allowed to shake at 
room temperature at 750 rpm for at least 5 hours. Products after derivatization were extracted with ethyl 
acetate, dried, and re-dissolved in 40% hexanes in ethyl acetate for the determination of enantiomeric 
excess. Purified compounds were dissolved in 40% isopropanol (IPA) in hexanes. 
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VI. Determination of Enantioselectivity and Assignment of Absolute Stereochemistry 
Absolute stereochemistry was assigned using commercial standards of (S)-2-amino-1-phenylethanol and 
(R)-2-amino-1-(4-methoxyphenyl)ethanol along with their racemic standards, 9 and 4. Comparison to the 
enzymatic reactions reveals the enzymatic major products to be the (R)-enantiomer. Absolute 
stereochemistry of other aminoalcohol products was assigned by analogy to be the (R)-enantiomer. 
Samples were analyzed using normal phase chiral HPLC using hexanes (hex) and isopropanol (IPA) as 
the mobile phase. All chiral HPLC traces were taken after derivatization with benzoyl chloride. All 
spectra were taken at 245 nm. For the analysis of products 4 – 15, Chiralpak IC column was used. 
Chiralcel OJ-H column was used for the analysis of product 16. 
Additionally, the commercial standards of (S)-2-amino-1-phenylethanol and (R)-2-amino-1-(4-
methoxyphenyl)ethanol were dissolved in the supernatant of centrifuged whole cell reaction mixtures 
quenched with acetonitrile, and were dried overnight in the fume hood. The standards were then 
derivatized by adding saturated sodium bicarbonate solution (50 µL) and benzoyl chloride stock solution 
(10 µL, 10% v/v in acetonitrile). Inversion or decrease in ee was not observed in this experiment. 
Assignment of absolute stereochemistry. 
Standard 
/ Method 
HPLC trace 
Derivatized 
9(racemic) 
 
85% hex. 
15% IPA 
2 mL/min 
12 minutes 
 
Derivatized 
9 (S) 
enantiomer 
standard 
 
S２２ 
Derivatized 
4 (racemic) 
 
80% hex. 
20% IPA 
2.5 mL/min 
10 minutes 
 
Derivatized 
4 (R) 
enantiomer 
standard 
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Determination of enantiomeric excess for P1 – P11. 
Analyte Chiral HPLC trace 
Derivatized 
4  
 
Racemic 
standard 
 
Derivatized 
4 
 
Enzymatic 
reaction 
 
(90% ee) 
 
  
S２４ 
Derivatized 
5 
 
Racemic 
standard 
 
80% hex. 
20% IPA 
2.5 mL/min 
12 minutes 
 
Derivatized 
5 
 
Enzymatic 
reaction 
 
(63% ee) 
 
Derivatized 
6 
 
Racemic 
standard 
 
80% hex. 
20% IPA 
2.5 mL/min 
12 minutes 
 
Derivatized 
6 
 
Enzymatic 
reaction 
 
(80% ee) 
 
S２５ 
Derivatized 
7 
 
Racemic 
standard 
 
85% hex. 
15% IPA 
2.5 mL/min 
10 minutes 
 
Derivatized 
7 
 
Enzymatic 
reaction 
 
(67% ee) 
 
Derivatized 
8 
 
Racemic 
standard 
 
80% hex. 
20% IPA 
2.5 mL/min 
12 minutes 
 
Derivatized 
8 
 
Enzymatic 
reaction 
 
(53% ee) 
 
S２６ 
Derivatized 
9 
 
Racemic 
standard 
 
85% hex. 
15% IPA 
2 mL/min 
12 minutes 
 
Derivatized 
9 
 
Enzymatic 
reaction 
 
(92% ee) 
 
Derivatized 
10 
 
Racemic 
standard 
 
90% hex. 
10% IPA 
2 mL/min 
12 minutes  
 
Derivatized 
10 
 
Enzymatic 
reaction 
 
(88% ee) 
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Derivatized 
11 
 
Racemic 
standard 
 
90% hex. 
10% IPA 
2 mL/min 
12 minutes 
 
Derivatized 
11 
 
Enzymatic 
reaction 
 
(92% ee) 
 
Derivatized 
12 
 
Racemic 
standard 
 
90% hex. 
10% IPA 
2 mL/min 
12 minutes 
 
Derivatized 
12 
 
Enzymatic 
reaction 
 
(82% ee) 
 
S２８ 
Derivatized 
13 
 
Racemic 
standard 
 
90% hex. 
10% IPA 
2 mL/min 
10 minutes 
 
Derivatized 
13 
 
Enzymatic 
reaction 
 
(80% ee) 
 
Derivatized 
14 
 
Racemic 
standard 
 
85% hex. 
15% IPA 
2.5 mL/min 
12 minutes 
 
Derivatized 
14 
 
Enzymatic 
reaction 
 
(85% ee) 
 
S２９ 
Derivatized 
15 
 
Racemic 
standard 
 
80% hex. 
20% IPA 
2.5 mL/min 
10 minutes 
 
Derivatized 
15 
 
Enzymatic 
reaction 
 
(45% ee) 
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Diastereomer assignment and ee determination of enzymatic reaction with trans-anethole .  
The 
1
H-NMR spectrum of commercially available racemic standard 2-amino-1-(4-
methoxyphenyl)propan-1-ol (16) was taken, and the diastereomeric ratio of this racemic standard was 
determined to be 4:1 between (1R,2R)-(1S,2S)-2-amino-1-(4-methoxyphenyl)propan-1-ol and (1R,2S)-
(1S,2R)-2-amino-1-(4-methoxyphenyl)propan-1-ol. Full spectrum of product 15 was: 
1
H NMR (500 MHz, 
DMSO-d6) δ 8.25 (s, 3H), 7.32 (d, J = 8.6 Hz, 2H), 6.98 (d, J = 8.5 Hz, 2H), 6.15 (d, J = 3.7 Hz, 1H, from 
threo diastereomer), 5.99 (d, J =  4.1 Hz, 1H, from erythro diastereomer), 4.85 (m, 1H, from erythro 
diastereomer), 4.36 (dd, J = 9, 3.5 Hz, 1H, from threo diastereomer), 3.82 (s, 3H), 3.26 (s, 1H), 0.98 (d, J 
= 6.5 Hz, 3H). The diastereomers were assigned by comparison to the 
1
H-NMR spectra of both 
diastereomers from the literature.
12
 
13
 
14
 
 
Next, chiral HPLC trace of commercial standard 16 after benzoyl chloride derivatization was taken. Two 
pairs of peaks with the absorbance ratio of 4:1 were identified, and were assigned as (1R,2R)-(1S,2S)-16 
and (1R,2S)-(1S,2R)-16, respectively. Finally, chiral HPLC trace of 16 obtained by enzymatic reaction 
was obtained after benzoyl chloride derivatization. The absolute configuration of the major diastereomer 
was assigned by analogy. 
S３１ 
Derivatized 
16 
 
Racemic 
standard 
 
85% hex. 
15% IPA 
2 mL/min 
12 minutes 
 
Derivatized 
16 
 
Enzymatic 
reaction 
 
(87:13 dr) 
(95% ee) 
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VII. Preparative Scale Biocatalytic Reactions 
BL21 E. cloni cells co-transformed with the pEC86 plasmid encoding ccmABCDEFG and pET22b(+) 
plasmid encoding Rma TQL variant were grown overnight in 15 mL LBamp/chl (37 °C, 230 rpm). HBamp/chl 
medium (800 mL) in a 2,000 mL flask was inoculated with 10 mL of the overnight culture. The HB 
culture was shaken at 37 °C and 250 rpm for 1 hours and 30 minutes, or until OD600 was 0.4-0.6. The 
culture was cooled on ice bath for 40 minutes, and then induced with 20 µM IPTG and 200 µM 5-
aminolevulinic acid (final concentrations). The culture was allowed to shake for 22 hours at 200 rpm in an 
incubator with temperature reduced to 22.5 °C. Cells expressing the TQL variant were pelleted by 
centrifugation (4,500 g, 7 minutes, 4 °C), resuspended in 0.1 M potassium phosphate buffer (pH 8.0) 
containing 150 mM sodium chloride, and adjusted to OD600 = 60. The cell suspension was then poured 
into a 125 mL Erlenmeyer flask, sealed with a rubber cap and parafilm, put on ice bath, and degassed by 
sparging with argon for 30 minutes. The vial was then transferred into an anaerobic chamber. 80 mL of 
argon-purged cells were transferred into a new 125 mL Erlenmeyer flask, and an oxygen depletion system 
(5 mL, 14,000 U/mL catalase and 1,000 U/mL glucose oxidase in 0.1 M KPi, pH 8.0) and glucose 
solution (10 mL, 250 mM in 0.1 M KPi, pH 8.0) were subsequently added. Finally, nitrene precursor N1 
and substrate S1 (5 mL each, 400 mM in DMSO) were added. The final reaction volume was 100 mL, 
and the amount of substrates added was 2.0 mmol each. The flask was sealed and the reaction proceeded 
at room temperature for 24 hours with stirring. The leftover cell suspension was used to determine the 
protein concentration using hemochrome assay. 
After the reaction was frozen overnight and thawed at room temperature, 200 mL of acetonitrile was 
added, and the mixture was shaken at room temperature for an hour. The mixture was transferred to 50 
mL falcon tubes and then centrifuged (5,000 g, 10 minutes). The analytical yield was determined by 
analyzing 200 µL of the supernatant with LC-MS (XDB-C8 column). The 200 µL sample was then dried, 
derivatized, and extracted into hexanes and ethyl acetate mixture to determine the analytical ee. The 
remaining supernatant was concentrated to less than 10 mL, filtered, and purified by silica gel column 
chromatography or semi-preparative reverse-phase HPLC column (XDB-C18 column). 
a. 2-Amino-1-(4-methoxyphenyl)ethanol (product 4). 
The reaction was performed on 2.0-mmol scale as described. The product was purified by C18 
chromatography (5 to 100% acetonitrile/water). Analytical yield of 80% and ee of 88% was measured. 
After purification and evaporation of solvent under reduced pressure, 204 mg (61% yield) of the product 
was obtained with 85% ee. This compound is known in the literature.
15
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1
H NMR (400 MHz, DMSO-d6) δ 8.34 (br s, 2H), 7.42 (d, J = 8.6 Hz, 2H), 7.03 (d, J = 8.5 Hz, 2H), 4.92 
(m, 1H), 3.81 (s, 3H), 3.15 (m, 2H). 
13
C NMR (400 MHz, DMSO-d6) δ 158.8 (1C), 135.7 (1C), 127.5 (2C), 115.8 (2C), 74.5 (1C), 55.4 (1C), 
50.5 (1C). 
 
b. 2-Amino-1-(4-methoxyphenyl)propan-1-ol (product 16). 
Two reactions on 0.5-mmol scale with the final reaction volume of 24 mL in 50 mL Erlenmeyer flasks 
were performed using whole cells resuspended to OD600 = 60. After the analytical yield (84%), dr (87:13), 
and ee (92%) were determined, the supernatants of the acetonitrile-quenched and centrifuged reaction 
mixture were combined and concentrated to less than 1 mL. The product was purified using semi-
preparative HPLC (XDB-C18 column, 5% to 95% acetonitrile/water with 0.1% acetic acid). The fractions 
containing the product were combined; the solvent was evaporated under reduced pressure. The product 
was obtained in 52% yield (95 mg) and the major diastereomer (dr 90:10) threo-2-amino-1-(4-
methoxyphenyl)propan-1-ol was obtained with 90% ee. 
Characterization for threo-16: 
1
H NMR (400 MHz, DMSO-d6) δ 7.95 (br s, 2H), 7.27 (d, J = 8.8 Hz, 2H), 
6.95 (d, J = 8.6 Hz, 2H), 6.01 (s, J = 3.6 Hz, 1H),  4.38 (d, J = 8.8 Hz, 1H), 3.74 (s, 3H), 3.17 (s, 1H), 
0.95 (d, J = 6.8 Hz, 3H). 
13
C NMR (400 MHz, DMSO-d6) δ 159.4 (1C), 133.8 (1C), 125.1 (2C), 114.1 (2C), 74.5 (1C), 53.6 (1C), 
52.8 (1C), 15.5 (1C). 
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VIII. Mechanistic Studies 
a. Aminohydroxylation in H2
18
O using purified protein. 
To each of three 2-mL screw cap vials, 200 μL of isotope-labeled water (H2
18
O) and 160 μL of 0.1 M KPi 
buffer (pH 8.0, with 150 mM NaCl) were added. Purified TQL variant was subsequently added to the 
final protein concentration of 20 μM in the total reaction volume of 400 μL. Sodium dithionite solution 
(15 μL/vial, 10 mg/mL in the 0.1 M KPi buffer) was added to the vials, and the vials were moved into 
anaerobic chamber. Nitrene source 1 and substrate 3 (10 μL each, 400 mM stocks in DMSO) were added 
separately. The vials were capped and allowed to shake at room temperature at 700 rpm. After 24 hours, 
the vials were taken out of the anaerobic chamber, and the reaction was quenched by adding acetonitrile 
(800 μL) to each of the vials. The reaction mixtures were transferred to 1.7-mL Eppendorf tubes, vortexed, 
and then centrifuged (14,000 g, 5 minutes) to separate the coagulated protein from supernatant. The 
supernatant from each tube was then transferred to a 2-mL screw cap vial, and was analyzed using LC-
MS (5% - 95% water to acetonitrile with 0.1% acetic acid). Based on the mass peak areas of unlabeled 
product 4 (M+H
+
 = 168) and 
18
O-labeled product 4 (M+H
+
 = 170), 47% of product 4 was 
18
O-labeled 
when 50% of the reaction buffer was of H2
18
O. 
 
b. Synthesis of racemic 2-phenylaziridine and separation of enantiomers. 
N-(p-tolylsulfonyl)-2-phenylaziridine was synthesized as previously reported in the procedure of T. Ando 
and coworkers.
16
 To a degassed solution of acetonitrile (100 mL, sparged with argon for 20 minutes) was 
added chloramine-T trihydrate (4.23 g, 15.0 mmol) and I2 (0.38 g, 1.5 mmol, 10 mol%). The headspace 
was then evacuated and filled again with argon three times. Next, styrene (3.12 g, 30.0 mmol) was added 
and the reaction was stirred at room temperature for 18 hours. The reaction mixture was diluted into 100 
mL dichloromethane. After adding 50 mL water, the mixture was extracted two times with 
dichloromethane (100 mL each). The combined organic solvent was concentrated under reduced pressure. 
Purification by silica column chromatography (hexanes : ethyl acetate = 6 : 1, with 1% trimethylamine) 
afforded N-(p-tolylsulfonyl)-2-phenylaziridine (3.55 g, 13.0 mmol, 87% yield) as a white solid. Spectral 
data were consistent with literature.
17
 
The tosyl-protected aziridine was then deprotected, following the procedure reported by R. A. Craig 
II and coworkers.
18
 Magnesium turnings (0.50 g, 21.1 mmol) were activated by washing with HCl (5% in 
water). The magnesium turnings were resuspended in methanol (40 mL), and N-(p-tolylsulfonyl)-2-
phenylaziridine (1.0 g, 3.7 mmol) in methanol (20 mL) was added to the suspension. The suspension was 
S３５ 
sonicated at room temperature until complete consumption of the starting material as indicated by thin 
layer chromatography. Brine (200 mL) was then added to the suspension. The aqueous layer was 
extracted four times with dichloromethane (150 mL each), and the combined organic layer was 
concentrated under reduced pressure. Purification by silica column chromatography (ethyl acetate in 
hexanes, 25% to 60% gradient, with 1% trimethylamine) afforded 2-phenylaziridine (0.27 g, 2.3 mmol, 
62% yield) as a clear oil. The spectral data were consistent with literature.
19
 
1
H NMR (400 MHz, CDCl3) 
δ 7.38 – 7.28 (m, 2H), 7.28 – 7.16 (m, 3H), 3.02 (dd, J = 6.3, 3.4 Hz, 1H), 2.21 (d, J = 6.1 Hz, 1H), 1.79 
(s, 1H), 0.74 (br s, 1H). 
The racemic phenylaziridine product was dissolved in hexanes (200 mM). The two enantiomers were 
separated and purified by multiple injections with chiral HPLC using Chiracel OJ-H column 
(hexanes/isopropanol). The excess solvents were removed under reduced pressure to obtain (S)-(+)-2-
phenylaziridine and (R)-(-)-2-phenylaziridine. The specific rotation of isolated (R)-(-)-2-phenylaziridine, 
[α]D -30° (c 0.5, CHCl3), was compared to the value reported in literature
18
 to assign the absolute 
configuration. The specific rotation of the (S)-(+)-2-phenylaziridine was found to be [α]D 29° (c 0.5, 
CHCl3). Both enantiomers were immediately dissolved in DMSO (100 mM) and stored at -20 °C. 
 
c. Hydrolysis time-course of 2-phenylaziridine. 
 
To fifteen 1.7-mL Eppendorf tubes containing M9-N medium (300 µL/tube, pH 7.4), racemic 
phenylaziridine stock solution (10 µL/tube, 200 mM in DMSO) was added. The tubes were shaken at 700 
rpm at room temperature for 4 hours. After 10 minutes, 30 minutes, 1 hours, 2 hours, and 4 hours, three 
Eppendorf tubes were taken out of the shaker. The solution in the tubes was basified by adding saturated 
sodium bicarbonate solution (50 µL/tube), and the remaining phenylaziridine was extracted with 50% 
ethyl acetate in hexanes. The amount of remaining phenylaziridine was determined by GC-MS analysis. 
This experiment was repeated using M9-N medium containing 10 µM TQL variant to monitor the 
S３６ 
degradation of racemic 2-phenylaziridine in the presence of the protein catalyst. An additional 
degradation experiment was performed using sodium acetate buffer (pH 5.0) instead of M9-N medium 
were performed to study the effect of pH in aziridine hydrolysis. The hydrolysis was observed to be 
facilitated if purified TQL variant is present. The hydrolysis was much faster in acidic acetate buffer (pH 
5.0) than in M9-N medium. 
 
d. Stereospecificity of 2-phenylaziridine hydrolysis. 
 
M9-N medium (300 µL/tube, pH 7.4) was added to six 1.7-mL Eppendorf tubes, and acetate buffer (300 
µL/tube, pH 5.0) was added to another set of six 1.7-mL Eppendorf tubes. To three of the tubes 
containing M9-N medium and three of the tubes containing acetate buffer, purified TQL variant was 
added to the final concentration of 10 µM. Racemic 2-phenylaziridine (200 mM in DMSO), (S)-2-
phenylaziridine, and (R)-2-phenylaziridine (100 mM in DMSO) were each added to two tubes with M9-N 
and two tubes with acetate buffer to the final concentration of 5 mM. All Eppendorf tubes were shaken at 
700 rpm at room temperature for 6 hours. Saturated sodium bicarbonate solution (50 µL/tube) was added 
to the tubes, which were washed subsequently with 50% ethyl acetate in hexanes to remove any 
unhydrolyzed 2-phenylaziridine from 2-amino-1-phenylethanol, the hydrolysis product. Benzoyl chloride 
solution (10 µL/tube, 10% in acetonitrile) was added to the remaining aqueous layer, and the tubes were 
shaken at 700 rpm at room temperature for 4 hours. The derivatized 2-amino-1-phenylethanol was 
extracted with 50% ethyl acetate in hexanes, dried, and then dissolved again in hexanes. The 
stereochemistry of this hydrolysis product was determined by chiral HPLC using Chiralcel OJ-H column 
(hexanes/isopropanol). The retention time was compared to the retention times of racemic 2-amino-1-
phenylethanol and (S)-2-amino-1-phenylethanol standards after derivatization. The (R)-2-phenylaziridine 
and (S)-2-phenylaziridine hydrolyzed to (S)-2-amino-1-phenylethanol and (R)-2-amino-1-phenylethanol, 
respectively, in both M9-N medium and acetate buffer with or without TQL variant. Racemic 
phenylaziridine hydrolyzed to racemic aminoalcohol. 
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e. Purified enzyme reactions in M9-N medium and acetate buffer. 
 
Four sets of time-course experiments with 11 time points were performed using purified TQL variant. 
Two sets were performed with M9-N medium (pH 7.4) as the solvent, whereas the other two sets were 
performed using acetate buffer (0.1 M, pH 5.0). Each set of experiments was conducted in the following 
manner. Reaction solvent (370 µL/vial) containing purified TQL variant (2 µM, final concentration) was 
pipetted to all eleven 2-mL screw cap vials. Sodium dithionite solution (10 µL/vial, 10 mg/mL in the 
matching reaction solvent) was added. The vials were moved into anaerobic chamber, where nitrene 
source 1 and substrate 3 (10 μL each, 200 mM stocks in DMSO) were added. The vials were capped and 
allowed to shake at room temperature at 700 rpm. After each time point (0.5, 1, 2, 5, 10, 30, 60, 120, 240, 
480, and 1440 minutes) had passed, reaction in one vial was quenched by adding 800 µL acetonitrile. 
Vials containing quenched reactions were immediately taken out of the anaerobic chamber. The reaction 
mixtures were transferred to 1.7-mL Eppendorf tubes, vortexed, and centrifuged (14,000 g, 5 minutes) to 
separate the protein from supernatant. To determine the TTN, 200 µL of the supernatant was transferred 
to a screw cap GC vial with 0.4-mL vial insert, and was analyzed using LC-MS (5% - 95% water to 
acetonitrile with 0.1% acetic acid). The remaining supernatant was dried until acetonitrile was removed, 
and the product in the aqueous solvent was derivatized with benzoyl chloride to determine the ee. 
 
 
f. Aminohydroxylation of substrate 3 with other nitrene precursors.  
S３８ 
 
Nitrene source Structure TTN e.e. after derivatization [%] 
1 
 
2300 90 
17 
 
1500 93 
18 
 
2100 92 
 
We performed aminohydroxylation of 3 using three additional unprotected nitrene precursors in 
phosphate buffer (0.1 M, pH 8.0). Aminohydroxylation of 3 with precursor 17 yielded 4 with 93% ee, 
while 18 yielded 4 with 92% ee. It is noteworthy that the identity of the nitrene precursor and the presence 
of the acid salt can affect the selectivity even when the reaction intermediate is presumably identical. 
Reactions were performed in whole cells expressing the TQL variant, resuspended in phosphate buffer 
(0.1 M, pH 8.0) to OD600 = 30, with 10 mM of each substrate. Reactions were set up inside an anaerobic 
chamber and were shaken at 600 rpm at room temperature for 18 hours. Results are the average of 
triplicate reactions. The values for e.e. were measured after derivatization with benzoyl chloride. 
 
g. Aminohydroxylation of substrate 3 at higher temperatures using purified TQL variant. 
Temperature 
pH 7.4 M9-N medium pH 5.0 acetate buffer 
TTN ee [%] TTN ee [%] 
37 °C 2900 89 1700 57 
42 °C 3200 77 2100 61 
50 °C 3300 59 3000 55 
 
Reactions were performed using purified TQL variant (10 µM final concentration) in the specified 
reaction buffer. Sodium dithionite solution (10 µL/reaction, 10 mg/mL in water) was added to reduce the 
iron cofactor of the hemoprotein. The final concentration of both reagents, 1 and 3, was 5 mM. The total 
S３９ 
reaction volume was 400 µL. Reactions were set up in an anaerobic chamber, capped, further sealed with 
parafilm, and then taken out of the anaerobic chamber. Reactions were shaken in an incubator adjusted to 
the specified reaction temperature at 300 rpm.  
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IX. Sequence Information 
a. Gene sequence of the wildtype Rma cytochrome c. 
gtttaactttaagaaggagatatacatATGAAATACCTGCTGCCGACCGCTGCTGCTGGTCTGCTGCTCCTCGCTGCCCAGCC
GGCGATGGCCATGACTGAAAGCGGGACTGCTGCACAAGACCCGGAAGCACTGGCAGCGGAAATTGGTCCGGTCA
AACAGGTGAGCCTGGGTGAACAGATTGATGCGGCCCTGGCGCAACAGGGAGAACAGCTCTTCAACACGTATTGT
ACTGCGTGCCACCGTCTGGATGAGCGTTTTATCGGACCGGCCCTGCGCGATGTTACCAAACGTCGTGGGCCGGTTT
ACATCATGAACGTGATGCTGAACCCGAATGGGATGATCCAGCGTCATCCGGTGATGAAACAGCTCGTGCAGGAAT
ATGGGACCATGATGACCGATATGGCCCTGAGTGAAGAACAAGCGCGCGCAATTCTGGAGTATCTGCGCCAGGTTG
CGGAAAACCAGCTCGAGCACCACCATCACCACCACTGA 
[1:27]: (gray, lowercase) N-terminus homology region 
[28:93]: (gray, uppercase) pelB 
[94:468]: (black, uppercase) Rma cytochrome c 
[469:495]: (gray, uppercase) Xho1, C-terminus His-Tag, stop codon 
b. Gene sequence of Rma cytochrome c variant TQL. 
gtttaactttaagaaggagatatacatATGAAATACCTGCTGCCGACCGCTGCTGCTGGTCTGCTGCTCCTCGCTGCCCAGCC
GGCGATGGCCATGACTGAAAGCGGGACTGCTGCACAAGACCCGGAAGCACTGGCAGCGGAAATTGGTCCGGTCA
AACAGGTGAGCCTGGGTGAACAGATTGATGCGGCCCTGGCGCAACAGGGAGAACAGCTCTTCAACACGACGTGT
ACTGCGTGCCACCGTCTGGATGAGCGTTTTATCGGACCGGCCCTGCGCGATGTTACCAAACGTCGTGGGCCGGTTT
ACATCATGAACGTGCAGCTGAACCCGAATGGGATGATCCAGCGTCATCCGGTGATGAAACAGCTCGTGCAGGAAT
ATGGGCTTGTGAGTCCGGATGGTGCCCTGAGTGAAGAACAAGCGCGCGCAATTCTGGAGTATCTGCGCCAGGTT
GCGGAAAACCAGctcgagcaccaccatcaccaccactga 
  Nucleotides marked in red are mutated from the wildtype gene. 
c. Amino acid sequence of the wildtype Rma cytochrome c. 
MKYLLPTAAAGLLLLAAQPAMAMTESGTAAQDPEALAAEIGPVKQVSLGEQIDAALAQQGEQLFNTYCTACHRLDERF
IGPALRDVTKRRGPVYIMNVMLNPNGMIQRHPVMKQLVQEYGTMMTDMALSEEQARAILEYLRQVAENQLEHHHH
HH* 
[1:22]: (gray, uppercase) pelB 
S４１ 
[23:147]: (black, uppercase) Rma cytochrome c 
[148:157]: (gray, uppercase) Xho1, C-terminus His-Tag, stop codon 
d. Amino acid sequence of variant TQL. 
MKYLLPTAAAGLLLLAAQPAMAMTESGTAAQDPEALAAEIGPVKQVSLGEQIDAALAQQGEQLFNTTCTACHRLDERF
IGPALRDVTKRRGPVYIMNVQLNPNGMIQRHPVMKQLVQEYGLVSPDGALSEEQARAILEYLRQVAENQLEHHHHH
H* 
Residues marked in red are mutated from the wildtype protein. 
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